Overall, the interaction between SESN2 and PDGFRβ in glioblastoma remains incompletely understood, and it is unclear whether PDGFRβ modulation by SESN2 significantly influences glioblastoma progression or reflects a broader regulatory mechanism. The gene discussed is PDGFRB; the disease is glioblastoma.